P2X7R : A Critical Regulator and Potential Therapeutic Target for Glioma
Journal of Neuroscience Research · 2025-07 · 103 (7)
DOI: 10.1002/jnr.70065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, online erschienen am 03.07.2025. Verfasst von Meng Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, China. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Glioma is the most common primary brain tumor, characterized by high invasiveness and poor prognosis. The purinergic ligand‐gated ion channel 7 receptor (P2X7R), an ion channel‐type purinergic receptor with adenosine triphosphate (ATP) as its ligand, is widely expressed in various tumor cells, including glioma. Moreover, it plays crucial biological functions in the progression of glioma. P2X7R promotes the proliferation, invasion, and metastasis of glioma by activating multiple signaling pathways, facilitating epithelial–mesenchymal transition (EMT), promoting the release of extracellular vesicles (EVs) and regulating the tumor microenvironment (TME) of glioma. However, the activation of P2X7R by high concentrations of ATP can induce cell necrosis or pyroptosis, exerting an anti‐glioma effect. The bidirectional nature of its functions may be related to differences in the subtypes of P2X7R, cell types, as well as the TME. P2X7R antagonists can inhibit its effect in glioma, while the expression of P2X7R can enhance the efficacy of radiotherapy and chemotherapy. In this review, the structure and function of P2X7R, its role in tumor, especially its mechanism of action in glioma, and its latent capacity value as a target for therapeutic of glioma were reviewed in detail.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Laboratory, Shandong Second Medical University, Weifang, Shandong, China.
- Shandong Advanced Academy Engineering Research Institute of Precision Medicine Innovation and Transformation of Infections Diseases, Shandong Second Medical University, Weifang, Shandong, China.
ORCID-Profile: Xiaoxiang Peng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yan, M., Zhao, R., Xue, Y., Cao, Y., Du, Y., & Peng, X. (2025). P2X7R : A Critical Regulator and Potential Therapeutic Target for Glioma. Journal of Neuroscience Research, 103(7). https://doi.org/10.1002/jnr.70065
Vancouver
Yan M, Zhao R, Xue Y, Cao Y, Du Y, Peng X. P2X7R : A Critical Regulator and Potential Therapeutic Target for Glioma. Journal of Neuroscience Research. 2025;103(7). doi:10.1002/jnr.70065
BibTeX
@article{Yan2025,
author = {Yan, Meng and Zhao, Ronglan and Xue, Yanwen and Cao, Yahui and Du, Yanan and Peng, Xiaoxiang},
title = {P2X7R : A Critical Regulator and Potential Therapeutic Target for Glioma},
journal = {Journal of Neuroscience Research},
year = {2025},
volume = {103},
number = {7},
doi = {10.1002/jnr.70065}
}
EUVIMED